Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
GSK gets maintenance indication for Trelegy
Among GSK’s other critical growth products shingles vaccine Shingrix made £110m in the first quarter - stronger than expected - while its HIV portfolio grew 6% to £1.05bn, which some analysts ... growth at constant exchange rates across its pharma,
Latest news
-
Sanofi sells European generics to Advent for $2.4bn
such as dengue fever vaccine Dengvaxia to deliver revenues as expected.
-
Sanofi backs vaccines unit with €350m Canadian facility
Sanofi backs vaccines unit with 350m Canadian facility. The new plant will make paediatric and booster vaccines. ... It demonstrates our continued commitment to manufacturing excellence and to better serving our vaccines portfolio to people all over the
-
Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal
For instance, it licensed CureVac ’s cancer vaccine CV9202 in 2014, formed a collaboration with Philogen seeking immunotherapies for acute myeloid leukaemia in 2015, and partnered an oncolytic virus therapy developed
-
The two ‘c’s’ of public health: confounding and causal inference*
Do people who get the flu vaccine have a lower mortality rate than those who don’t get vaccinated? ... Does the vaccine increase survival? Or are those who get vaccinated less sick than those who don’t get vaccinated?
-
GSK buys Novartis out of consumer health JV after ditching Pfizer bid
its vaccine assets.
More from news
Approximately 106 fully matching, plus 1,002 partially matching documents found.
Latest Intelligence
-
Uncertainty, austerity and Brexit
Newer plans to lower the QALY for vaccines to £15, 000 should alarm all companies, as it suggests that the QALY for all medicines could also be lowered. ... This is essential. Vaccines are an interesting case study for the post-Brexit world.
-
Health on instalment
The only apt parallel might be the discovery of antibiotics or vaccines, but even those milestones may end up paling in comparison.
-
Deal Watch January 2018
Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales of GSK's QS-21 containing vaccines. ... In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.
-
The good, the bad and the ugly
This was driven largely by higher-than-expected sales of its pneumonia vaccine, Prevnar, which accounted for more than 11% of its total revenues in the third quarter of 2017.
-
Gene therapy
From a payload perspective, these include new technologies such as siRNA, Sleeping Beauty transposases, CRISPR-Cas9 gene editing, ARCUS gene editing, nucleic acid vaccines, oncolytic viruses and chemically modified mRNA. ... Looking to the future, there
More from intelligence
Approximately 5 fully matching, plus 73 partially matching documents found.
Latest appointments
-
Bone Therapeutics strengthens board with new chairman
He has also been a member of the corporate executive team for GlaxoSmithKline and chief executive officer of GSK Biologicals (now GSK Vaccines).
-
McCann Health appoints Daniel Carucci as global medical director
Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health
-
Professor Carole Longson moves from NICE to the ABPI
and the role our members play in developing new innovative medicines and vaccines.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
-
Relay Therapeutics appoints Sarah O’Brien as VP of HR
Prior to Sobi, O’Brien spent seven years working at Novartis for its vaccines arm and then with the Novartis Institute for Biomedical Research (NIBR), where she worked closely with the
More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Infographic: The vaccine opportunity in Asia
Infographic: The vaccine opportunity in Asia. As predicted, the vaccine market in emerging and developing countries has continued to expand. ... Download our latest infographic in which we explore the vaccine opportunity in Asia.
-
Case Study: Private market opportunity for a travel vaccine
Case Study: Private market opportunity for a travel vaccine. Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. ... travel. Who the key stakeholders were in each market, in terms of
-
Exploring the Opportunity For Halal In Healthcare
As pork is forbidden by Islam, the use of pork-based gelatin in many vaccines has resulted in considerable resistance to vaccination among the Islamic community. ... Data has demonstrated a decrease in immunization rates in majority Muslim countries such
-
emotive. expands Medical Writing and Client Services teams
Working for a number of award-winning agencies, he has broad experience across multiple therapy areas including diabetes, haematology, immunology, iron deficiency, oncology and vaccines.
-
emotive Account Management team boosted following recent pitch wins
Following a series of recent pitch wins spanning e-learning, medical education, disease awareness and consumer facing websites for clients such as Novartis Vaccines, VirginCare, Novo Nordisk and Takeda, emotive have
More from PMHub
Approximately 3 fully matching, plus 24 partially matching documents found.
Featured jobs
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Senior Programme Executive
-
Salary TBC
- Account Manager – Med Comms – London
-
Salary TBC
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and bebefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Scientific Director
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
Subscribe to our email news alerts
PMHub
Lucid Group Communications Limited
We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...
Latest intelligence
- No Voice, No Choice
- Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
Quick links
Infographics
